Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

NCT00414310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Acute Myelogenous Leukemia

Interventions

DRUG: Decitabine
DRUG: Valproic Acid

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]